Daniel Gilden, MS

Original Research

Gabapentin Lawsuit Among Patients with Bipolar

October 16, 2012

Read our full evaluation on the $430 million gabapentin off-label marketing lawsuit and how it affected patients diagnosed with bipolar disorder.